Continuous Subcutaneous Levodopa Delivery for Parkinson’s Disease: A Randomized Study

202059 citationsJournal Articlebronze Open Access

Authors

C. Warren Olanow · Icahn School of Medicine at Mount Sinai

for the 006 study group · University of Cincinnati

Alberto J. Espay · Vita-Salute San Raffaele University

Fabrizio Stocchi · Vita-Salute San Raffaele University

Aaron Ellenbogen · Quest Research Institute

Mika Leinonen · NeuroDerm (Israel)

Liat Adar ·

Abstract

This study demonstrates the feasibility and safety of continuous subcutaneous delivery of levodopa as a treatment for PD and provides preliminary evidence of efficacy.

Topics & Keywords

Neurological disorders and treatments Parkinson's Disease Mechanisms and Treatments Transcranial Magnetic Stimulation Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Parkinson s Disease

Volume 11, Issue 1, pp. 177-186

DOI: 10.3233/jpd-202285

Field-Weighted Citation Impact: 2.78